Vaccine Manufacture and Supply – News and Features

Explore cutting-edge technologies and workflows advancing downstream processing in biopharma, driving purification efficiency and innovation in new therapies.

A vaccine under development at the University at Buffalo has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu.

Contamination is one of the main roadblocks to successful cell culture. This article explores the different types of contamination, how to identify microbial contaminants in cell culture and best practices for removal and prevention.

Researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine using virus-like particles (VLPs).

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from COVID-19 and influenza and broader immunity to different flu strains.

Spider silk has created something of a furor in the biomanufacturing world as businesses look for ways to cheaply scale up silk production.

The ability to obtain pure proteins is essential for developing drugs, creating vaccines and understanding biological processes. In this article, we discuss what a typical protein purification protocol involves and the various techniques used.

Scott Ripley explores how realizing the potential of mRNA therapeutics will require the standardization of processes, manufacturing agility and collaboration between industry, academia and government bodies.

Vaccines are the most cost-effective strategy to prevent and suppress global infections. This article explores innovative strategies and technologies shaping the production of vaccines, ensuring rapid development, scalability and global accessibility.

A type of nanoparticle can activate a powerful immune response, showing promise for use as both the vaccine delivery system and as an adjuvant.